Literature DB >> 2018750

Sebaceous and meibomian carcinomas of the eyelid. Recognition, diagnosis, and management.

J A Khan1, J F Doane, A S Grove.   

Abstract

Sebaceous carcinoma of the eyelid is frequently misdiagnosed clinically and histopathologically. The tumor may present as a lid mass, recurrent chalazion, or diffuse unilateral blepharoconjunctivitis. Fifty percent of cases are misdiagnosed, often by an inexperienced general pathologist interpreting the initial biopsy. Frozen-section monitoring of surgical margins has been reported unreliable in 25% of cases. Mohs surgery is also unreliable in cases where there is pagetoid intraepithelial spread or skip lesions. This tumor may spread regionally into the lacrimal secretory and excretory systems, to regional lymph nodes, and rarely disseminate hematogenously. Guidelines for management are discussed.

Entities:  

Mesh:

Year:  1991        PMID: 2018750     DOI: 10.1097/00002341-199103000-00008

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  10 in total

1.  Sebaceous carcinoma of the eyelid: a clinicopathological study.

Authors:  M Zürcher; C R Hintschich; A Garner; C Bunce; J R Collin
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea.

Authors:  Youn Joo Choi; Hyun Chul Jin; Min Joung Lee; Namju Kim; Ho-Kyung Choung; Sang In Khwarg
Journal:  Jpn J Ophthalmol       Date:  2014-04-25       Impact factor: 2.447

3.  Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.

Authors:  S Kaliki; A Ayyar; T V Dave; M J Ali; D K Mishra; M N Naik
Journal:  Eye (Lond)       Date:  2015-05-22       Impact factor: 3.775

Review 4.  Sebaceous Carcinoma: A Review of the Scientific Literature.

Authors:  Thomas Knackstedt; Faramarz H Samie
Journal:  Curr Treat Options Oncol       Date:  2017-08

5.  The practice patterns in the management of sebaceous carcinoma of the eyelid in the Asia Pacific region.

Authors:  Janice J C Cheung; Bita Esmaeli; Stacey C Lam; Tracey Kwok; Hunter K L Yuen
Journal:  Eye (Lond)       Date:  2019-04-05       Impact factor: 3.775

6.  A case of giant advanced sebaceous gland carcinoma.

Authors:  Deevish Dinakar; Rajashekara Babu; Sadashivaiah Shivaswamy
Journal:  Indian J Surg Oncol       Date:  2013-07-14

7.  Immunohistochemical staining for adipophilin, perilipin and TIP47.

Authors:  K Muthusamy; G Halbert; F Roberts
Journal:  J Clin Pathol       Date:  2006-03-23       Impact factor: 3.411

8.  Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.

Authors:  Swathi Kaliki; Adit Gupta; Mohammed Hasnat Ali; Anuradha Ayyar; Milind N Naik
Journal:  Int Ophthalmol       Date:  2016-02-01       Impact factor: 2.031

9.  Advanced upper eyelid sebaceous gland carcinoma with deep orbital extension.

Authors:  Syed Ali Raza Rizvi; Veena Maheshwari
Journal:  J Surg Case Rep       Date:  2010-03-01

10.  Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma.

Authors:  Tiina Leivo; Johanna Sarmela; Maria Enckell-Aaltonen; Eva Dafgård Kopp; Caroline Schmitt; Peter B Toft; Haraldur Sigurdsson; Marita Uusitalo
Journal:  BMC Ophthalmol       Date:  2020-03-16       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.